— Frontload

My resting heart rate lived around 51 for years. Ten months on retatrutide it topped out at 69. Here is what is actually going on, whether it is something to worry about, and the four things that helped.

I started retatrutide last November. Within the first two days I noticed my resting heart rate creeping up on my WHOOP. It had lived around 51 for as long as I had tracked it.

It kept creeping. As I titrated the dose up over the next several months, my resting heart rate climbed to the high 50s, into the 60s, and topped out at 69. That is 18 beats above where I started. I have the whole thing as a graph because the app pulls my resting heart rate off my WHOOP every day, and there is nothing like watching that line march up month after month to send you looking for answers.

I noticed it most when I was doing nothing. Sitting on the couch, I would feel my heart working harder than it should be at rest. And it hit my sleep the worst. Lying in bed aware of a fast heartbeat is its own kind of misery, and it is what eventually pushed me to fix my sleep. I did not spiral about it though. I looked it up, learned that a higher resting heart rate is a known and expected effect of these drugs, and kept moving while I worked out what to do.

If you are on reta or thinking about it, this question comes up constantly in the communities, so here is what I found.

It climbs with the dose

Every drug in this class nudges resting heart rate up. It is not a reta quirk, it is a class effect, and it is written right into the FDA labels. Semaglutide, the GLP-1 in Ozempic and Wegovy, runs about 1 to 4 beats per minute higher on average. Tirzepatide, the GIP and GLP-1 drug in Mounjaro and Zepbound, runs about 2 to 4. Both labels say the effect is dose related.

That was exactly my experience. My heart rate did not jump all at once, it stepped up as my dose stepped up, and it stalled out whenever I held a dose steady.

Reta is the strongest of the three on this, and it is the one I am on. It hits three receptors, GIP, GLP-1, and glucagon, and the glucagon piece is the one people point to for the extra beats. That is my hunch too, given how hard it pushed my number. But I am not going to hand you that as fact, because the science does not close the case. Nobody has run these three drugs head to head on heart rate, reta’s numbers were measured differently and at higher doses than the label figures for the other two, and other drugs that hit the glucagon receptor do not clearly raise heart rate more than plain GLP-1s do. So the fair version is: reta looks like the biggest hitter, but the clean ranking and the glucagon blame are not settled.

Worth understanding what this is, because it is not a stimulant. Caffeine or a pre-workout gives you a spike that you feel and that fades in a few hours. This is different. These drugs act directly on the sinus node, your heart’s own pacemaker, with some help from your nervous system, and the result is a shift in your baseline. That is why it sits there at rest and follows you to bed instead of buzzing and wearing off.

Does it go away

The trial data and the real world do not fully agree here.

In reta’s own trial, the average heart rate rise peaked around week 24 and then eased off while people stayed on the drug. That is the reassuring version. But spend time in the reta communities and you will see plenty of people whose resting heart rate went up and simply stayed up the entire time they were on it, sometimes 10 to 15 beats above baseline for months. Others settled back close to normal. What is consistent is that it tracks your dose, it stabilizes when you hold steady, and for people who stop the drug, it tends to fall back toward baseline within a couple of weeks.

Mine did not fully return to 51. It leveled off once I stopped titrating, and then came down a few beats with the changes below. I have made my peace with a resting heart rate that sits a little higher while I am on this.

Is it something to worry about

For the two approved drugs, the trial record is reassuring. The big semaglutide cardiovascular trial, SELECT, found it cut major cardiac events by about 20 percent, even with the small heart rate bump, and alongside weight loss and lower blood pressure. Tirzepatide’s label calls the clinical relevance of the heart rate increase uncertain.

Reta is where I would hold the reassurance. It is not FDA approved yet. Its weight-loss trials have read out, but the big cardiovascular outcomes trial, the one that would actually tell us whether this heart rate rise matters over years, has not reported and is not expected to until 2027 at the earliest. So of the three, reta is the one we have the least long-term heart data on. That is not a reason to panic, it is a reason to pay attention.

I will be honest about my own choices: I never took this to a doctor and I never got my heart checked. That was my call for me, and it is not the call I would tell you to copy. If your resting heart rate takes a sustained jump, if you feel real palpitations, or if you are already starting from a high number, that is a conversation with your doctor, not a forum. The labels track jumps of 15 to 20 beats for a reason, and Wegovy’s label literally says to stop the drug for a sustained increase.

What actually helped

Four things moved the needle for me.

Holding the dose. My heart rate only climbed while I was titrating up. Every time I sat on a dose, it stabilized. Rushing the titration is the fastest way to spike it.

Cardio. I added one hard zone 3 to zone 4 session a week and I walk ten thousand steps a day, and my resting heart rate came down a few beats from its peak. That is not a reta trick, it is just fitness. The research on aerobic training shows it drops resting heart rate by roughly 3 to 9 beats per minute, which is the same range as the rise these drugs cause. Your fitness can absorb the hit.

Hydration. Reta kills your thirst right along with your appetite, and it is easy to get quietly dehydrated in the first few weeks, which drives your heart rate up all by itself. Staying on top of water and electrolytes is worth doing no matter what.

Magnesium and melatonin. These did not lower my heart rate, they fixed the sleep the heart rate was wrecking. Different problem, and worth separating.

Mostly, watch it. I would not have caught any of this, or known that holding a dose calmed it down, if I were not looking at my resting heart rate trend every day. A number you can see is a number you can actually do something about. I built Frontload so my resting heart rate sits on the same screen as the protocol and the dose log driving it. You can also read more about retatrutide in the compound library, free, no account.

Frequently asked questions

Does retatrutide raise your resting heart rate?

For me, yes, and it is a known effect of the whole GLP-1 class, not a reta quirk. Mine went from around 51 to a peak of 69 as I titrated the dose up, and it stepped up with the dose rather than jumping all at once. The FDA labels put semaglutide at about 1 to 4 beats per minute higher on average and tirzepatide at about 2 to 4, both dose related. Reta looks like the strongest of the three on this, though the clean ranking is not settled.

Is the heart rate increase from GLP-1 drugs dangerous?

For the two approved drugs the trial record is reassuring. The big semaglutide outcomes trial, SELECT, cut major cardiac events by about 20 percent even with the heart rate bump, and tirzepatide’s label calls the clinical relevance uncertain. Retatrutide is where I hold the reassurance, because it is not FDA approved yet and its cardiovascular outcomes trial has not reported and is not expected until 2027 at the earliest, so it has the least long-term heart data of the three. That is a reason to pay attention, not to panic. A sustained jump, real palpitations, or a high starting number is a conversation with your doctor.

Will my resting heart rate go back to normal on reta?

The trial and the real world do not fully agree. In reta’s own trial the average rise peaked around week 24 and then eased off while people stayed on the drug. But in the communities plenty of people report their resting heart rate went up and stayed up the whole time they were on it, sometimes 10 to 15 beats above baseline for months, while others settled back near normal. What is consistent is that it tracks your dose, stabilizes when you hold steady, and for people who stop, it tends to fall back toward baseline within a couple of weeks. Mine did not fully return to 51; it leveled off and came down a few beats.

How do I lower my heart rate on a GLP-1?

Four things helped me. Holding the dose, because mine only climbed while I was titrating up. One hard cardio session a week plus ten thousand steps a day; aerobic training lowers resting heart rate by roughly 3 to 9 beats per minute, the same range as the drug’s rise. Staying on top of hydration and electrolytes, because reta kills your thirst along with your appetite and quiet dehydration drives heart rate up on its own. And magnesium and melatonin, which did not lower my heart rate but fixed the sleep it was wrecking.

Why does retatrutide raise heart rate more than semaglutide?

It looks like it does, and the usual explanation is that reta hits the glucagon receptor on top of GIP and GLP-1. That is my hunch too, but I will not hand it to you as fact. Nobody has run these three drugs head to head on heart rate, reta’s numbers were measured differently and at higher doses than the label figures for the others, and other drugs that hit the glucagon receptor do not clearly raise heart rate more than plain GLP-1s. So the fair version is that reta looks like the biggest hitter, but the clean ranking and the glucagon blame are not settled.

Sources

The numbers here are my own resting heart rate data, pulled daily off my WHOOP into the app, on my own retatrutide protocol. That makes them real and it makes them a sample of one. Nothing about my heart rate generalizes to anyone else.
The class effect is in the labels. The FDA prescribing information for semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) reports the average resting heart rate increases, describes them as dose related, and Wegovy’s label says to consider stopping the drug for a sustained increase.
The trial pattern comes from reta’s own phase 2 data (Jastreboff et al., New England Journal of Medicine, 2023), where the average heart rate rise peaked around week 24 and then eased while people stayed on the drug.
The reassurance on the approved drugs comes from SELECT (Lincoff et al., NEJM, 2023), which found semaglutide cut major cardiac events by about 20 percent despite the heart rate bump.
Retatrutide is not FDA approved as of September 2026, and its cardiovascular outcomes trial has not reported, expected 2027 or later. That is why it has the least long-term heart data of the three.
Cardio lowering resting heart rate is general, not GLP-1 specific (Reimers et al., Journal of Clinical Medicine, 2018), which puts aerobic training’s effect at roughly 3 to 9 beats per minute.
What I deliberately do not claim: a clean ranking of these three drugs on heart rate, or that glucagon is the proven cause of reta’s larger effect. No head-to-head trial exists, and the mechanism is contested.

This is my own experience and general education, not medical advice. It is not a recommendation to start, change, or stop retatrutide or any GLP-1 drug, or to change a dose or titration schedule. Retatrutide is an investigational drug that is not FDA approved. Every person has different physiology and risks, so talk to a qualified medical provider about your own, especially if your resting heart rate rises and stays up.

Retatrutide Ran My Resting Heart Rate From 51 to 69. Here’s What’s Actually Going On.